Association of IRS-1 and IRS-2 genes polymorphisms with polycystic ovary syndrome: A meta-analysis

Endocrine Journal

Volumn 59, Issue 7, 2012, Pages 601-609

  Ruan, Yuan ^a   Ma, Jianhua ^a   Xie, Xiaojing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Insulin receptor substrate; Meta analysis; Polycystic ovary syndrome; Polymorphisms

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2;

ARTICLE; CONTROLLED STUDY; ETHNICITY; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HIGH RISK POPULATION; HUMAN; INSULIN RECEPTOR SUBSTRATE 1 GENE; INSULIN RECEPTOR SUBSTRATE 2 GENE; OVARY POLYCYSTIC DISEASE; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW;

AMINO ACID SUBSTITUTION; ARGININE; ASPARTIC ACID; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; GEOGRAPHY; GLYCINE; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84865634838     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ11-0387     Document Type: Article

References (39)

1. Ehrmann DA (2005) Polycystic ovary syndrome. N Engl J Med 352: 1223-1236.
2. Norman RJ, Dewailly D, Legro RS, Hickey TE (2007) Polycystic ovary syndrome. Lancet 370: 685-697.
3. Legro RS (2003) Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocrinol Rev 24: 302-312.
4. Legro RS, Strauss JF (2002) Molecular progress in infertility: polycystic ovary syndrome. Fertil Steril 78: 569-576.
5. Legro RS, Gnatuk CL, Kunselman AR, Dunaif A (2005) Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab 90: 3236-3242.
6. Maitra A, Pingle RR, Menon PS, Naik V, Gokral JS, et al. (2001) Dyslipidemia with particular regard to apolipoprotein profile in association with polycystic ovary syndrome: A study among Indian women. Int J Fertil Womens Med 46: 271-277.
7. Dunaif A, Wu X, Lee A, Diamanti-Kandarakis E (2001) Defects in insulin receptor Signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol Endocrinol Metab 281: E392-E399.
8. Legro RS, (1998) Insulin resistance in polycystic ovary syndrome:treating a phenotype without a genotype. Mol Cell Endocrinol 145: 103-110.
9. Escobar-Morreale HF, Luque-Ramírez M, San Millán JL (2005) The molecular-genetic basis of functional hyperandrogenismand the polycystic ovary syndrome. Endocr Rev 26: 251-282.
10. Simoni M, Tempfer CB, Destenaves B, Fauser BC (2008) Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Hum Reprod Update 14: 459-484.
11. Ehrmann DA, Tang X, Yoshiuchi I, Cox NJ, Bell GI (2002) Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome. J Clin Endocrinol Metab 87: 4297-4300.
12. El Mkadem SA, Lautier C, Macari F, Molinari N, Lefebvre P, et al. (2001) Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate- to-severe insulin resistance of women with polycystic ovary syndrome. Diabetes 50: 2164-2168.
13. Villuendas G, Botella-Carretero JI, Roldan B, Sancho J, Escobar-Morreale HF, et al. (2005) Polymorphisms in the insulin receptor substrate-1 (IRS-1) gene and the insulin receptor substrate-2 (IRS-2) gene influence glucose homeostasis and body mass index in women with polycystic ovary syndrome and non-hyperandrogenic controls. Hum Reprod 20: 3184-3191.
14. Dilek S, Ertunc D, Tok EC, Erdal EM, Aktas A (2005) Association of Gly972Arg variant of insulin receptor substrate-1 with metabolic features in women with polycystic ovary syndrome. Fertil Steril 84: 407-412.
15. Lin TC, Yen JM, Gong KB, Kuo TC, Ku DC, et al. (2006) Abnormal glucose tolerance and insulin resistance in polycystic ovary syndrome amongst the Taiwanese population not correlated with insulin receptor substrate-1 Gly972Arg/Ala513Pro polymorphism. BMC Med Genet 7: 36.
16. Ioannidis A, Ikonomi E, Niki L, Dimou, Douma L, et al. (2010) Polymorphisms of the insulin receptor and the insulin receptor substrates genes in polycystic ovary syndrome: A Mendelian randomization meta-analysis. Mol Genet Metab 99: 174-183.
17. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127: 820-826.
18. Lin YS, Tsai SJ, Lin MW, Yang CT, Huang MF, et al. (2011) Interleukin-6 as an Early Chronic Inflammatory Marker in Polycystic Ovary Syndrome with Insulin Receptor Substrate-2 Polymorphism. Am J Reprod Immunol 66: 527-533.
19. Christopoulos P, Mastorakos G, Gazouli M, Deligeoroglou E, Katsikis I, et al. (2010) Study of association of IRS-1 and IRS-2 genes polymorphisms with clinical and metabolic features in women with polycystic ovary syndrome. Is there an impact? Gynecol Endocrinol 26: 698-703.
20. Pappalardo MA, Russo GT, Pedone A, Pizzo A, Borrielli I, et al. (2010) Very high frequency of the polymorphism for the insulin receptor substrate 1 (IRS-1) at codon 972(glycine972arginine) in Southern Italian women with polycystic ovary syndrome. Horm Metab Res 42: 575-584.
21. Dravecká I, Lazúrová I, Habalová V (2010) The prevalence of Gly972Arg and C825T polymorphisms in Slovak women with polycystic ovary syndrome and their relation to the metabolic syndrome. Gynecol Endocrinol 26: 356-360.
22. Marioli DJ, Koika V, Adonakis GL, Saltamavros AD, Karela A, et al. (2010) No association of the G972S polymorphism of the insulin receptor substrate-1 gene with polycystic ovary syndrome in lean PCOS women with biochemical hyperandrogenemia. Arch Gynecol Obstet 281: 1045-1049.
23. Haap M, Machicao F, Stefan N, Thamer C, Tschritter O, et al. (2005) Genetic determinants of insulin action in polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 113: 275-281.
24. Valdés P, Cerda A, Barrenechea C, Kehr M, Soto C, et al. (2008) No association between common Gly972Arg variant of the insulin receptor substrate-1 and polycystic ovary syndrome in Southern Chilean women. Clin Chim Acta 390: 63-66.
25. Baba T, Endo T, Sata F, Honnma H, Kitajima Y, et al. (2007) Polycystic ovary syndrome is associated with genetic polymorphism in the insulin signaling gene IRS-1 but not ENPP1 in a Japanese population. Life Sci 81: 850-854.
26. Witchel SF, Kahsar-Miller M, Aston CE, White C, Azziz R (2005) Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess. Fertil Steril 83: 371-375.
27. Sir-Petermann T, Angel B, Maliqueo M, Santos JL, Riesco MV, et al. (2004) Insulin Secretion in Women Who Have Polycystic Ovary Syndrome and Carry the Gly972Arg Variant of Insulin Receptor Substrate-1 in Response to a High-Glycemic or Low-Glycemic Carbohydrate Load. Nutrition 20: 905-910.
28. Witchel SF, Smith R, Tomboc M, Aston CE (2001) Candidate gene analysis in premature pubarche and adolescent hyperandrogenism. Fertil Steril 75: 724-730.
29. Sir-Petermann T, Pérez-Bravo F, Angel B, Maliqueo M, Calvillan M, et al. (2001) G972R polymorphism of IRS-1 in women with polycystic ovary syndrome. Diabetologia 44: 1200-1201.
30. Ciaraldi TP, el-Roeiy A, Madar Z, Reichart D, Olefsky JM, et al. (1992) Cellular mechanisms of insulin resistance in polycystic ovarian syn-drome. J Clin Endocrinol Metab 75: 577-583.
31. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, et al. (1992) Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 41: 1257-1266.
32. White MF (1998) The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Recent Prog Horm Res 53: 119-138.
33. Kanai F, Ito K, Todaka M (1993) Insulin-stimulated GLUT4 translocation is relevant to the phosphorylation of IRS-1 and the activity of PI3-kinase. Biochem Biophys Res Commun 195: 762-768.
34. Okada T, Kawano Y, Sakakibara T, Osamu H, Ui M (1994) Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipoysis in rat adipocytes. J Biol Chem 269: 3568-3573.
35. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, et al. (1994) Phosphatidylinositol 3-kinase activation, is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol 14: 4902-4911.
36. Marchand-Brustel Y, Gautier N, Cormont M, Van Obberghen E (1995) Wortmannin inhibits the action of insulin but not that of okadaic acid in skeletal muscle. Comparison with fat cells. Endocrinology 136: 3564-3570.
37. Lawrence JC, Roach PJ (1997) New insights into the role and mechanism of glycogen synthase activation by insulin. Diabetes 46: 541-547.
38. Chen ZJ, Zhao H, He L, Shi Y, Qin Y, et al. (2011) Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet 43: 55-59.
39. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K (2002) A comprehensive review of genetic association studies. Genet Med 4: 45-61.